There are 2949 resources available
Live Q&A - 18 September 2020 - 17:00-18:00
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
An overview of NSCLC
Presenter: Marina Garassino
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Uncommon EGFR mutations in NSCLC
Presenter: Zofia Piotrowska
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:30-18:00
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
12P - Genome mining-aided biosynthesis overcomes Temozolomide-resistant glioblastoma via negatively regulating cIAP-mediated degradation of PACS2 and ER-mitochondria contact sites
Presenter: Lei Chen
Session: E-Poster Display
Resources:
Abstract
13P - Synergistic activity of PARP inhibitor and ATR inhibitor in melanoma cell lines may depend on BRAF-V600 mutation status
Presenter: Emilio Giunta
Session: E-Poster Display
Resources:
Abstract
10P - Targeting Angiomotin-p130 reverse resistance to antiangiogenic therapies in breast cancer by inhibition of vasculogenic mimicry
Presenter: Yanwei Shen
Session: E-Poster Display
Resources:
Abstract
11P - Preclinical evaluation of DS-2087b, a novel and selective inhibitor of EGFR/HER2 exon 20 insertions
Presenter: Yasuhito Nagamoto
Session: E-Poster Display
Resources:
Abstract
14P - Modulation of MCF-7 cell sensitivity to anticancer agents by targeting glycolysis
Presenter: Alexander Scherbakov
Session: E-Poster Display
Resources:
Abstract